Forkhead Box Transcription Factors: Double-Edged Swords in Cancer

Maria Castaneda1, Petra den Hollander1, Sendurai A Mani1

  • 1Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer Research
|March 22, 2022
PubMed

Insights

Forkhead box (FOX) transcription factors are crucial in cancer progression and drug resistance. Targeting these pioneering factors offers a promising strategy for developing more effective cancer therapeutics.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Current cancer therapeutics face limitations due to side effects and resistance.
  • Targeted cancer treatments are needed to overcome these challenges.
  • Forkhead box (FOX) transcription factors are implicated in various biological processes relevant to cancer.

Purpose of the Study:

  • To review the multifaceted roles of FOX transcription factors in cancer.
  • To explore their function as pioneering factors in tumorigenesis.
  • To assess their potential as druggable targets for novel cancer therapies.

Main Methods:

  • Literature review of existing research on FOX transcription factors in cancer.
  • Analysis of the involvement of specific FOX factors (e.g., FOXA1, FOXM1) in cancer-related pathways.
  • Discussion of their regulatory roles in hormone signaling, immune modulation, and epithelial-mesenchymal transition.

Main Results:

  • FOX transcription factors regulate key biological processes that promote cancer development, progression, and metastasis.
  • These factors are involved in both intrinsic and acquired drug resistance mechanisms.
  • FOX factors act as pioneering factors, influencing chromatin accessibility and gene expression in cancer cells.

Conclusions:

  • FOX transcription factors represent a significant area of focus for targeted cancer therapy development.
  • Understanding their roles as pioneering factors is critical for designing effective therapeutic strategies.
  • Targeting FOX factors holds potential for overcoming treatment resistance and improving patient outcomes.

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
78.6K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K